Improving the diagnosis of tuberculosis: old and new laboratory tools

References

• World Health Organisation. Global Tuberculosis report 2022. Geneva; 2022 [cited 2024 Mar 21]. Available from: https://apps.who.int/bookorders
   Google Scholar
• England K, Masini T, Fajardo E. Detecting tuberculosis: rapid tools but slow progress. Public Health Action. 2019 Nov 2;9(3):80–83. doi: 10.5588/pha.19.0013
   PubMed Web of Science ®Google Scholar
• Shingadia D, and Burgner D. Mycobacterial Infections. In: Taussig LM, Landau LI, editors. Pediatric Respiratory Medicine. 2nd ed. Philadelphia, USA:Mosby; 2008. doi: 10.1016/B978-032304048-8.50043-8
   Google Scholar
• Steingart KR, Henry M, Ng V, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006;6(9):570–581. doi: 10.1016/S1473-3099(06)70578-3
   PubMed Web of Science ®Google Scholar
• Rasool G, Khan AM, Mohy-Ud-Din R, et al. Detection of mycobacterium tuberculosis in afb smear-negative sputum specimens through MTB culture and GeneXpert® MTB/RIF assay. Int J Immunopathol Pharmacol. 2019;33:205873841982717. doi: 10.1177/2058738419827174
   Web of Science ®Google Scholar
• World Health Organization. Module 3: Diagnosis. WHO consolidated guidelines on tuberculosis Rapid diagnostics for tuberculosis detection. 3rd ed. 2021.
   Google Scholar
• Maitra A, Solanki P, Sadouki Z, et al. Improving the drug development pipeline for mycobacteria: modelling antibiotic exposure in the hollow fibre infection model. Antibiotics. 2021 Dec 1;10(12):1515. doi: 10.3390/antibiotics10121515
   Google Scholar
• Joloba ML, Johnson JL, Feng PJI, et al. What is the most reliable solid culture medium for tuberculosis treatment trials? Tuberculosis. 2014;94(3):311–316. doi: 10.1016/j.tube.2014.03.002
   PubMed Web of Science ®Google Scholar
• Pheiffer C, Carroll † NM, Beyers N, et al. Time to detection of Mycobacterium tuberculosis in BACTEC systems as a viable alternative to colony counting. Int J Tuberc Lung Dis. 2008;12(7):792–798.
   PubMed Web of Science ®Google Scholar
• Morgan MA, Horstmeier CD, Deyoung DR, et al. Comparison of a radiometric method (BACTEC) and conventional culture media for recovery of mycobacteria from smear-negative specimens. J Clin Microbiol. 1983;18(2):384–388. doi: 10.1128/jcm.18.2.384-388.1983
   PubMed Web of Science ®Google Scholar
• Satta G, Lipman M, Smith GP, et al. Mycobacterium tuberculosis and whole-genome sequencing: how close are we to unleashing its full potential? Clin Microbiol Infect. 2018;24:604–609. doi: 10.1016/j.cmi.2017.10.030
   PubMed Web of Science ®Google Scholar
• Louie A, Duncanson B, Myrick J, et al. Activity of moxifloxacin against mycobacterium tuberculosis in acid phase and nonreplicative-persister phenotype phase in a hollow-fiber infection model. Antimicrob Agents Chemother. 2018;62(12). doi: 10.1128/AAC.01470-18
   Web of Science ®Google Scholar
• Mukamolova GV, Turapov O, Malkin J, et al. Resuscitation-promoting factors reveal an occult population of tubercle bacilli in sputum. Am J Respir Crit Care Med. 2010 Jan 15;181(2):174–180. doi: 10.1164/rccm.200905-0661OC
   PubMed Web of Science ®Google Scholar
• Rosser A, Stover C, Pareek M, et al. Resuscitation-promoting factors are important determinants of the pathophysiology in Mycobacterium tuberculosis infection. Crit Rev Microbiol. 2017;43:621–630. doi: 10.1080/1040841X.2017.1283485
   PubMed Web of Science ®Google Scholar
• Van Loon W, Gomez MP, Jobe D, et al. Use of resuscitation promoting factors to screen for tuberculosis infection in household-exposed children in the Gambia. BMC Infect Dis. 2020 Jul 2;20(1). doi: 10.1186/s12879-020-05194-1
   PubMed Web of Science ®Google Scholar
• Shield CG, Swift BMC, McHugh TD, et al. Application of bacteriophages for mycobacterial infections, from diagnosis to treatment. Microorganisms. 2021 Nov 1;9(11):2366. doi: 10.3390/microorganisms9112366
   PubMed Web of Science ®Google Scholar
• Penn-Nicholson A, Gomathi SN, Ugarte-Gil C, et al. A prospective multicentre diagnostic accuracy study for the truenat tuberculosis assays. Eur Respir J. 2021 Nov 1;58(5):2100526. doi: 10.1183/13993003.00526-2021
   PubMed Web of Science ®Google Scholar
• Biswas S, Uddin MKM, Paul KK, et al. Xpert MTB/RIF Ultra assay for the detection of Mycobacterium tuberculosis in people with negative conventional Xpert MTB/RIF but chest imaging suggestive of tuberculosis in Dhaka, Bangladesh. Inter J Infect Dis. 2022 Jan 1;114:244–251. doi: 10.1016/j.ijid.2021.11.010
   PubMed Web of Science ®Google Scholar
• Singh UB, Singh M, Sharma S, et al. Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF. Sci Rep [Internet]. 2023 Apr 28;13(1):6976. Available from: https://www.nature.com/articles/s41598-023-32810-2
   PubMed Web of Science ®Google Scholar
• Bruker. Tuberculosis rapid diagnostics of tuberculosis and its resistances your benefits with the TB product series from Hain Lifescience • Fast and reliable results • Step-wise diagnostics • Cost efficiency • CE-marked Innovation with Integrity PCR/MYCOBACTERIA IVD hain lifescience-a bruker company. 2023.
   Google Scholar
• Lin M, Chen YW, Li YR, et al. Systematic evaluation of line probe assays for the diagnosis of tuberculosis and drug-resistant tuberculosis. Clinica Chimica Acta. 2022 Aug 1;533:183–218. doi: 10.1016/j.cca.2022.06.020
   PubMed Web of Science ®Google Scholar
• Vaezipour N, Fritschi N, Brasier N, et al. Towards accurate point-of-care tests for tuberculosis in children. Pathogens. 2022 Mar 1;11(3):327. doi: 10.3390/pathogens11030327
   PubMed Web of Science ®Google Scholar
• David A, de Vos M, Scott L, et al. Feasibility, ease-of-use, and operational characteristics of world health organization–recommended moderate-complexity automated nucleic acid amplification tests for the detection of tuberculosis and resistance to rifampicin and isoniazid. J Mol Diagn. 2023 Jan 1;25(1):46–56. doi: 10.1016/j.jmoldx.2022.10.001
   PubMed Web of Science ®Google Scholar
• WHO. Information sheet: practical considerations for implementation of the nipro genoscholar PZA-TB II assay. 2021.
   Google Scholar
• MacLean E, Kohli M, Weber SF, et al. Advances in molecular diagnosis of tuberculosis. J Clin Microbiol. 2020;58(10). doi: 10.1128/JCM.01582-19
   PubMed Web of Science ®Google Scholar
• Olbrich L, Nliwasa M, Sabi I, et al. Rapid and accurate diagnosis of pediatric tuberculosis disease: a diagnostic accuracy study for pediatric Tuberculosis. Pediatr Infect Dis J. 2023 May 16;42(5):353–360. doi: 10.1097/INF.0000000000003853
   PubMed Web of Science ®Google Scholar
• Meldau R, Randall P, Pooran A, et al. Same-day tools, including xpert ultra and IRISA-TB, for rapid diagnosis of pleural tuberculosis: A prospective observational study. J Clin Microbiol. 2019;57(9). doi: 10.1128/JCM.00614-19
   PubMed Web of Science ®Google Scholar
• Sutherland JS, Van Der Spuy G, Gindeh A, et al. Diagnostic accuracy of the cepheid 3-gene host response fingerstick blood test in a prospective, multi-site study: interim results. Clin Infect Dis. 2022 Jun 15;74(12):2136–2141. doi: 10.1093/cid/ciab839
   PubMed Web of Science ®Google Scholar
• Amini S, Hoffner S, Allahyar Torkaman MR, et al. Direct drug susceptibility testing of Mycobacterium tuberculosis using the proportional method: a multicenter study. J Glob Antimicrob Resist. 2019 Jun 1;17:242–244. doi: 10.1016/j.jgar.2018.12.022
   PubMed Web of Science ®Google Scholar
• Yusoof KA, García JI, Schami A, et al. Tuberculosis phenotypic and genotypic drug susceptibility testing and immunodiagnostics: a review. Front Immunol. 2022;13. doi: 10.3389/fimmu.2022.870768
   PubMed Web of Science ®Google Scholar
• Becton D. BACTECTM MGITTM 960 SIRE kits for the antimycobacterial susceptibility testing of mycobacterium tuberculosis. 2019.
   Google Scholar
• World Health Organisation. Optimized broth microdilution plate methodology for drug susceptibility testing of mycobacterium tuberculosis complex [Internet]. 2022 [cited 2024 Mar 21]. Available from: http://apps.who.int/bookorders
   Google Scholar
• Lee J, Armstrong DT, Ssengooba W, et al. Sensititre MYCOTB MIC plate for testing mycobacterium tuberculosis susceptibility to first-and second-Line drugs. Antimicrob Agents Chemother. 2014 Jan;58(1):11–18. doi: 10.1128/AAC.01209-13
   PubMed Web of Science ®Google Scholar
• Solanki P, Lipman M, McHugh TD, et al. Whole genome sequencing and prediction of antimicrobial susceptibilities in non-tuberculous mycobacteria. Front Microbiol. 2022 Nov 29;13:13. doi: 10.3389/fmicb.2022.1044515
   Web of Science ®Google Scholar
• Pillay S, Steingart KR, Davies GR, et al. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin. Cochrane Database Syst Rev. 2022;2022. doi: 10.1002/14651858.CD014841.pub2
   Google Scholar
• Jouet A, Gaudin C, Badalato N, et al. Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs. Eur Respir J. 2021 Mar 1;57(3):2002338. doi: 10.1183/13993003.02338-2020
   PubMed Web of Science ®Google Scholar
• Papaventsis D, Casali N, Kontsevaya I, et al. Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review. Clin Microbiol Infect. 2017;23:61–68. doi: 10.1016/j.cmi.2016.09.008
   PubMed Web of Science ®Google Scholar
• Quail MA, Smith M, Coupland P, et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics. 2012 Jul 24;13(1):341. doi: 10.1186/1471-2164-13-341
   PubMedGoogle Scholar
• Cechova M. Probably correct: Rescuing repeats with short and long reads. Genes (Basel). 2021;12(1):1–13. doi: 10.3390/genes12010048
   Web of Science ®Google Scholar
• Quainoo S, Coolen JPM, van Hijum SAFT, et al. Whole-genome sequencing of bacterial pathogens: The future of nosocomial outbreak analysis. Clin Microbiol Rev. 2017;30(4):1015–1063. doi: 10.1128/CMR.00016-17
   PubMed Web of Science ®Google Scholar
• Kumar KR, Cowley MJ, Davis RL. Next-generation sequencing and emerging technologies. Semin Thromb Hemost. 2019;45(7):661–673. doi: 10.1055/s-0039-1688446
   PubMed Web of Science ®Google Scholar
• Liu L, Li Y, Li S, et al. Comparison of next-generation sequencing systems. J Biomed And Biotech. 2012;2012. doi: 10.1155/2012/251364
   Google Scholar
• Slatko BE, Gardner AF, Ausubel FM. Overview of next-generation sequencing technologies. Curr Protoc Mol Biol. 2018 Apr 1;122(1). doi: 10.1002/cpmb.59
   PubMedGoogle Scholar
• Oxford Nanopore Technologies. MinION Starter Pack. 2023.
   Google Scholar
• Oxford Nanopore Technologies. MinION Mk1B it requirements Overview [Internet]. [cited 2023 Jun 30]. Available from: https://www.techpowerup.com/gpu-specs/
   Google Scholar
• Kent L, McHugh TD, Billington O, et al. Demonstration of Homology between IS6110 of Mycobacterium tuberculosis and DNAs of Other Mycobacterium spp. J Clin Microbiol. 1995;33(9):2290–2293. doi: 10.1128/jcm.33.9.2290-2293.1995
   PubMed Web of Science ®Google Scholar
• Goig GA, Cancino-Muñoz I, Torres-Puente M, et al. Articles whole-genome sequencing of mycobacterium tuberculosis directly from clinical samples for high-resolution genomic epidemiology and drug resistance surveillance: an observational study. Lancet Microbe. 2020;1(4):e175–e183. doi: 10.1016/S2666-5247(20)30060-4
   PubMedGoogle Scholar
• Nilgiriwala K, Rabodoarivelo MS, Hall MB, et al. Genomic sequencing from sputum for tuberculosis disease diagnosis, lineage determination, and drug susceptibility prediction. J Clin Microbiol. 2023 Mar 23;61(3). doi: 10.1128/jcm.01578-22
   PubMed Web of Science ®Google Scholar
• Brown AC, Bryant JM, Einer-Jensen K, et al. Rapid whole-genome sequencing of mycobacterium tuberculosis isolates directly from clinical samples. J Clin Microbiol. 2015 Jul 1;53(7):2230–2237. doi: 10.1128/JCM.00486-15
   PubMed Web of Science ®Google Scholar
• Nimmo C, Doyle R, Burgess C, et al. Rapid identification of a Mycobacterium tuberculosis full genetic drug resistance profile through whole genome sequencing directly from sputum. Inter J Infect Dis. 2017 Sep 1;62:44–46. doi: 10.1016/j.ijid.2017.07.007
   PubMed Web of Science ®Google Scholar
• George S, Xu Y, Sanderson N, et al. MinION nanopore sequencing of multiple displacement amplified mycobacteria DNA 2 Direct from Sputum 3 4 5 short title: nanopore sequencing of mycobacteria DNA amplified direct from Sputum. doi: 10.1101/490417
   Google Scholar
• de Araujo L, Cabibbe AM, Mhuulu L, et al. Implementation of targeted next-generation sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings: a programmatic model, challenges, and initial outcomes. Front Public Health. 2023;11:11. doi: 10.3389/fpubh.2023.1204064
   Web of Science ®Google Scholar
• Chen P, He Y, Sun W. Comparison of metagenomic next-generation sequencing technology, culture and GeneXpert MTB/RIF assay in the diagnosis of tuberculosis. J Thorac Dis. 2020 Aug 1;12(8):4014–4024. doi: 10.21037/jtd-20-1232
   PubMed Web of Science ®Google Scholar
• Ebenezer TE, Muigai AWT, Nouala S, et al. Africa: sequence 100,000 species to safeguard biodiversity Setting the agenda in research. Nature Picture Library. 2022;603(7901):388–392. doi: 10.1038/d41586-022-00712-4
   Google Scholar
• H3Africa Human Heredity & Health in Africa [Internet]. 2023 [cited 2023 Jun 30]. Available from: https://h3africa.org/
   Google Scholar
• Akintayo Akintola A, Tunde Aborode A, Aborode AT. Africa needs more bioinformaticians for population studies. Nature. 2022;605(7911):619–619. doi: 10.1038/d41586-022-01378-8
   Web of Science ®Google Scholar
• CABANA Partners. CABANA. Capacity building for bioinformatics in Latin America [Internet]. 2019 [cited 2023 Jun 30]. Available from: https://www.cabana.online/contact
   Google Scholar
• EMBL-EBi. Mykrobe [Internet]. 2020 [cited 2023 Jun 30]. Available from: https://www.mykrobe.com/
   Google Scholar
• Sekizuka T, Yamashita A, Murase Y, et al. TGS-TB: Total genotyping solution for Mycobacterium tuberculosis using short-read whole-genome sequencing. PLOS ONE. 2015 Nov 1;10(11):e0142951. doi: 10.1371/journal.pone.0142951
   PubMed Web of Science ®Google Scholar
• Phelan JE, O’Sullivan DM, Machado D, et al. Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs. Genome Med. 2019 Jun 24;11(1). doi: 10.1186/s13073-019-0650-x
   PubMedGoogle Scholar
• Feuerriegel S, Schleusener V, Beckert P, et al. PhyResSE: A web tool delineating Mycobacterium tuberculosis antibiotic resistance and lineage from whole-genome sequencing data. J Clin Microbiol. 2015 Jun 1;53(6):1908–1914. doi: 10.1128/JCM.00025-15
   PubMed Web of Science ®Google Scholar
• Quagliaro P, Dziri S, Magdoud El Alaoui F, et al. Performances of bioinformatics tools for the analysis of sequencing data of Mycobacterium tuberculosis complex strains. Tuberculosis. 2023 Mar 1;139:102324. doi: 10.1016/j.tube.2023.102324
   PubMed Web of Science ®Google Scholar
• Satta G, Atzeni A, McHugh TD. Mycobacterium tuberculosis and whole genome sequencing: a practical guide and online tools available for the clinical microbiologist. Clin Microbiol Infect. Elsevier B.V.; 2017;23:69–72. doi: 10.1016/j.cmi.2016.09.005
   PubMed Web of Science ®Google Scholar
• Park M, Lalvani A, Satta G, et al. Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance. BMC Infect Dis. 2022 Dec 1;22(1). doi: 10.1186/s12879-022-07329-y
   Web of Science ®Google Scholar
• Olaru ID, Patel H, Kranzer K, et al. Turnaround time of whole genome sequencing for mycobacterial identification and drug susceptibility testing in routine practice. Clin Microbiol Infect. 2018 Jun 1;24(6):.e659.5–.e659.7. doi: 10.1016/j.cmi.2017.10.001
   Web of Science ®Google Scholar
• Bateson A, Ortiz Canseco J, McHugh TD, et al. Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid. J Antimicrob Chemother. 2022 May 29;77(6):1685–1693. doi: 10.1093/jac/dkac070
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Tuberculosis in South-East Asia Region. 2023 [cited2024 Jun 03]. https://www.who.int/southeastasia/health-topics/tuberculosis
   Google Scholar
• Perrin FMR, Woodward N, Phillips PPJ, et al. Radiological cavitation, sputum mycobacterial load and treatment response in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2010;14(12):1596–1602.
   PubMed Web of Science ®Google Scholar
• Honeyborne I, McHugh TD, Phillips PPJ, et al. Molecular bacterial load assay, a culture-free biomarker for rapid and accurate quantification of sputum mycobacterium tuberculosis bacillary load during treatment. J Clin Microbiol. 2011 Nov;49(11):3905–3911. doi: 10.1128/JCM.00547-11
   PubMed Web of Science ®Google Scholar
• Honeyborne I, Mtafya B, Phillips PPJ, et al. The molecular bacterial load assay replaces solid culture for measuring early bactericidal response to antituberculosis treatment. J Clin Microbiol. 2014;52(8):3064–3067. doi: 10.1128/JCM.01128-14
   PubMed Web of Science ®Google Scholar
• Evangelopoulos D, Whittaker E, Honeyborne I, et al. Pediatric tuberculosis-human immunodeficiency virus co-infection in the United Kingdom highlights the need for better therapy monitoring tools: a case report. J Med Case Rep. 2017 Feb 26;11(1). doi: 10.1186/s13256-017-1222-6
   PubMedGoogle Scholar
• Sabiiti W, Azam K, Farmer ECW, et al. Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis molecular bacterial load assay. Thorax. 2020;75(7):606–608. doi: 10.1136/thoraxjnl-2019-214238
   PubMed Web of Science ®Google Scholar
• Cui Z, Wang Y, Fang L, et al. Novel real-time simultaneous amplification and testing method to accurately and rapidly detect Mycobacterium tuberculosis complex. J Clin Microbiol. 2012 Mar;50(3):646–650. doi: 10.1128/JCM.05853-11
   PubMed Web of Science ®Google Scholar
• Friedrich SO, Rachow A, Saathoff E, et al. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment. Lancet Respir Med. 2013 Aug;1(6):462–470. doi: 10.1016/S2213-2600(13)70119-X
   PubMed Web of Science ®Google Scholar
• Kayigire XA, Friedrich SO, Venter A, et al. Direct comparison of Xpert MTB/RIF assay with liquid and solid mycobacterial culture for quantification of early bactericidal activity. J Clin Microbiol. 2013 Jun;51(6):1894–1898. doi: 10.1128/JCM.03290-12
   PubMed Web of Science ®Google Scholar
• Minion J, Leung E, Talbot E, et al. Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. Eur Respir J. 2011;38(6):1398–1405. doi: 10.1183/09031936.00025711
   PubMed Web of Science ®Google Scholar
• Walter ND, Born SEM, Robertson GT, et al. Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens. Nat Commun. 2021 Dec 1;12(1). doi: 10.1038/s41467-021-22833-6
   Web of Science ®Google Scholar
• Nogueira BMF, Krishnan S, Barreto‐Duarte B, et al. Diagnostic biomarkers for active tuberculosis: progress and challenges. EMBO Mol Med. 2022 Dec 7;14(12). doi: 10.15252/emmm.202114088
   PubMed Web of Science ®Google Scholar
• Gupta-Wright A, den Boon S, MacLean E, et al. Target product profiles: tests for tuberculosis treatment monitoring and optimization. Bull World Health Organ. 2023 Nov 1;101(11):730–737. doi: 10.2471/BLT.23.290901
   PubMed Web of Science ®Google Scholar
• Gunasekera KS, Vonasek B, Oliwa J, et al. Diagnostic challenges in childhood pulmonary tuberculosis—optimizing the clinical approach. Pathogens. MDPI; 2022;11(4):382. doi: 10.3390/pathogens11040382
   PubMed Web of Science ®Google Scholar
• García-Basteiro AL, DiNardo A, Saavedra B, et al. Point of care diagnostics for tuberculosis. Revista Portuguesa de Pneumologia (English Edition). Elsevier Doyma; 2018;24(2):73–85. doi: 10.1016/j.rppnen.2017.12.002
   Google Scholar
• Carranza C, Pedraza-Sanchez S, de Oyarzabal-Mendez E, et al. Diagnosis for latent tuberculosis infection: new alternatives. Front Immunol. Frontiers Media S.A.; 2020;11. doi: 10.3389/fimmu.2020.02006
   PubMed Web of Science ®Google Scholar
• Schwartzman K, Menzies D. Letters Correspondance Getting in line [Internet]. 2000 [cited 2024 Mar 21]. Available from: www.cma.ca/cmaj
   Google Scholar
• NICE. Tuberculosis NICE guideline Your responsibility [Internet]. 2016 [cited 2024 Mar 21]. Available from: www.nice.org.uk/guidance/ng33
   Google Scholar
• Nikolayevskyy V, Niemann S, Anthony R, et al. Role and value of whole genome sequencing in studying tuberculosis transmission. Clin Microbiol Infect. Elsevier B.V.; 2019;25:1377–1382. doi: 10.1016/j.cmi.2019.03.022
   PubMed Web of Science ®Google Scholar
• Roetzer A, Diel R, Kohl TA, et al. Whole genome sequencing versus traditional genotyping for investigation of a mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study. PLOS Med. 2013;10(2):e1001387. doi: 10.1371/journal.pmed.1001387
   PubMed Web of Science ®Google Scholar
• Estée Török M, Reuter S, Bryant J, et al. Rapid whole-genome sequencing for investigation of a suspected tuberculosis outbreak. J Clin Microbiol. 2013 Feb;51(2):611–614. doi: 10.1128/JCM.02279-12
   PubMed Web of Science ®Google Scholar
• Stucki D, Ballif M, Bodmer T, et al. Tracking a tuberculosis outbreak over 21 years: Strain-specific single-nucleotide polymorphism typing combined with targeted whole-genome sequencing. J Infect Dis. Oxford University Press; 2015;211(8):1306–1316. doi: 10.1093/infdis/jiu601
   PubMed Web of Science ®Google Scholar
• Liu Y, Qu HQ, Mentch FD, et al. Application of deep learning algorithm on whole genome sequencing data uncovers structural variants associated with multiple mental disorders in African American patients. Mol Psychiatry. 2022 Mar 1;27(3):1469–1478. doi: 10.1038/s41380-021-01418-1
   PubMed Web of Science ®Google Scholar
• Ren Y, Chakraborty T, Doijad S, et al. Prediction of antimicrobial resistance based on whole-genome sequencing and machine learning. Bioinformatics. 2022 Jan 15;38(2):325–334. doi: 10.1093/bioinformatics/btab681
   PubMed Web of Science ®Google Scholar
• Sharma A, Machado E, Lima KVB, et al. Tuberculosis drug resistance profiling based on machine learning: a literature review. Brazil J Infect Dis. 2022;26(1):102332. doi: 10.1016/j.bjid.2022.102332
   PubMed Web of Science ®Google Scholar